G
Genomic Valley Biotech
GVBL Share Price
Healthcare24.99
as on 13 Mar 2026 at 15:15
BSE
Market Cap
₹8 Cr
PE Ratio
-167.50
ROCE
11.32%
GVBL Fundamentals
Company Valuation
Market Cap (₹ Cr.)
8
PE Ratio
-167.50
PB Ratio
1.96
Dividend Yield
-
ROE
9.13%
ROCE
11.32%
Book Value (₹)
12.85
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 46.83% | 46.78% | 46.72% | 46.72% | 46.06% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 52.59% | 52.62% | 52.79% | 52.53% | 52.25% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GVBL Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Biotechnology
Company Classification
Microcap
BSE Scrip Code
539206
NSE Scrip Name
GVBL
ISIN
INE574D01010



